Avanos Medical, Inc.
Avanos Medical, Inc.（AVNS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AVNS · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
4
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Avanos Medical, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AVNS 季度内部人买卖趋势
AVNS 内幕交易卖出 · AVNS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AVNS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AVNS 高管卖出股份 · AVNS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 22, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 4,228 | $104K | Form 4 |
| Apr 22, 2026 | Delgado Sigfrido SVP, Operations | Other | 4,264 | $105K | Form 4 |
| Apr 14, 2026 | Pacitti David CEO | Other | 21,194 | $308K | Form 4 |
| Mar 13, 2026 | Hurley John Joseph PAO | Award | 2,211 | — | Form 4 |
| Mar 13, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Award | 29,481 | — | Form 4 |
| Mar 13, 2026 | Pacitti David CEO | Award | 101,341 | — | Form 4 |
| Mar 13, 2026 | Delgado Sigfrido SVP, Operations | Award | 15,886 | — | Form 4 |
| Mar 9, 2026 | Hurley John Joseph PAO | Other | 226 | $3K | Form 4 |
| Mar 9, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 1,119 | $15K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Option | 919 | $13K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Other | 321 | $4K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Other | 144 | $2K | Form 4 |
| Mar 6, 2026 | Hurley John Joseph PAO | Other | 211 | $3K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Option | 5,907 | $81K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 2,356 | $32K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 1,057 | $15K | Form 4 |
| Mar 6, 2026 | Galovan Scott Michael SVP, Chief Financial Officer | Other | 2,041 | $28K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 13,834 | $152K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 100 | $1K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 761 | $8K | Form 4 |
| Nov 18, 2025 | Holbrook Kerr SVP, Chief Commercial Officer | Sale | 305 | $3K | Form 4 |
| Sep 5, 2025 | Hurley John Joseph PAO | Other | 345 | $4K | Form 4 |
| Aug 13, 2025 | BLACKFORD GARY Director | Purchase | 20,000 | $220K | Form 4 |
| Aug 13, 2025 | BLACKFORD GARY Director | Purchase | 40,000 | $440K | Form 4 |
| May 13, 2025 | Greiner Michael Former Interim CEO | Other | 19,771 | $246K | Form 4 |
Galovan Scott Michael
SVP, Chief Financial Officer
日期
Apr 22
股数
4,228
均价
$24.64
总金额
$104K
Galovan Scott Michael
SVP, Chief Financial Officer
日期
Mar 9
股数
1,119
均价
$13.29
总金额
$15K
Galovan Scott Michael
SVP, Chief Financial Officer
日期
Mar 6
股数
5,907
均价
$13.79
总金额
$81K
Galovan Scott Michael
SVP, Chief Financial Officer
日期
Mar 6
股数
2,356
均价
$13.79
总金额
$32K
Galovan Scott Michael
SVP, Chief Financial Officer
日期
Mar 6
股数
1,057
均价
$13.79
总金额
$15K
Galovan Scott Michael
SVP, Chief Financial Officer
日期
Mar 6
股数
2,041
均价
$13.79
总金额
$28K
Holbrook Kerr
SVP, Chief Commercial Officer
日期
Nov 18
股数
13,834
均价
$11.00
总金额
$152K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AVNS 内幕交易
AVNS 内幕交易
Avanos Medical, Inc.（AVNS）内幕交易数据来源于公司内部人（包括Galovan Scott Michael (SVP, Chief Financial Officer), Hurley John Joseph (PAO), Holbrook Kerr (SVP, Chief Commercial Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。AVNS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Avanos Medical, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AVNS 内幕交易 · 5个问题Avanos Medical, Inc.（AVNS）的内部人包括高管和董事，如Galovan Scott Michael (SVP, Chief Financial Officer), Hurley John Joseph (PAO), Holbrook Kerr (SVP, Chief Commercial Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026